Abgenix, Inc. (ABGX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Abgenix, Inc. (ABGX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: nigel bates	3/29/2006 5:46:31 PM
	Read Replies (1) of 590

Abgenix Announces Stockholder Approval of Acquisition by Amgen Wednesday March 29, 5:10 pm ET FREMONT, Calif., March 29 /PRNewswire-FirstCall/ -- At a special meeting held today, stockholders of Abgenix, Inc. (Nasdaq: ABGX - News) overwhelmingly approved the acquisition of Abgenix by Amgen. Approximately 71 percent of the outstanding shares of Abgenix common stock were voted in favor of the transaction. This represents more than 99 percent of the shares that were voted at the meeting. On December 14, 2005, Abgenix and Amgen announced they had entered into an agreement for Amgen to acquire Abgenix for $22.50 per share of Abgenix Common Stock plus the assumption of Abgenix debt. Consummation of the merger is subject to other customary closing conditions and is expected to be completed on April 1, 2006...

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next